Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong

SUMMARY Background Coronavirus disease 2019 (COVID-19) was first reported in Wuhan in December 2019 and has rapidly spread across different cities within and outside China. Hong Kong started to prepare for COVID-19 on 31st December 2019 and infection control measures in public hospitals were tightened to limit nosocomial transmission within healthcare facilities. However, the recommendations on the transmission-based precautions required for COVID-19 in hospital settings vary from droplet and contact precautions, to contact and airborne precautions with placement of patients in airborne infection isolation rooms. Aim To describe an outbreak investigation of a patient with COVID-19 who was nursed in an open cubicle of a general ward before the diagnosis was made. Method Contacts were identified and risk categorized as ‘close’ or ‘casual’ for decisions on quarantine and/or medical surveillance. Respiratory specimens were collected from contacts who developed fever, and/or respiratory symptoms during the surveillance period and were tested for SARS-CoV-2. Findings A total of 71 staff and 49 patients were identified from contact tracing, seven staff and 10 patients fulfilled the criteria of ‘close contact’. At the end of 28-day surveillance, 76 tests were performed on 52 contacts and all were negative, including all patient close contacts and six of the seven staff close contacts. The remaining contacts were asymptomatic throughout the surveillance period. Conclusion Our findings suggest that SARS-CoV-2 is not spread by an airborne route, and nosocomial transmissions can be prevented through vigilant basic infection control measures, including wearing of surgical masks, hand and environmental hygiene.

[1]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[2]  A. Simonds,et al.  Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. , 2010, Health technology assessment.

[3]  U. Buchholz,et al.  The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011 , 2012, BMC Infectious Diseases.

[4]  Peter Cameron,et al.  A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[5]  B. Cowling,et al.  Facemasks and Hand Hygiene to Prevent Influenza Transmission in Households , 2009, Annals of Internal Medicine.

[6]  E. Galanis,et al.  Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[7]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[8]  K. Cimon,et al.  Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review. , 2011, CADTH technology overviews.

[9]  W. Liang,et al.  Clinical characteristics of 2019 novel coronavirus infection in China , 2020, medRxiv.

[10]  D. Hui,et al.  Aerosol dispersion during various respiratory therapies: a risk assessment model of nosocomial infection to health care workers. , 2014, Hong Kong medical journal = Xianggang yi xue za zhi.

[11]  K. To,et al.  Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan , 2020, Emerging microbes & infections.

[12]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[13]  R. Gandhi Clinical Characteristics of 2019 Novel Coronavirus Infection , 2020 .

[14]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[15]  Xilin Yang,et al.  SARS Transmission, Risk Factors, and Prevention in Hong Kong , 2004, Emerging infectious diseases.

[16]  J. Rocklöv,et al.  The reproductive number of COVID-19 is higher compared to SARS coronavirus , 2020, Journal of travel medicine.

[17]  Xiong He,et al.  Risk Factors for SARS among Persons without Known Contact with SARS Patients, Beijing, China , 2004, Emerging infectious diseases.

[18]  G. Leung,et al.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study , 2020, The Lancet.

[19]  L. Yang,et al.  Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, International Journal of Infectious Diseases.

[20]  Weili Yang,et al.  Severe acute respiratory syndrome (SARS): infection control , 2003, The Lancet.

[21]  China Cdc Weekly The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020 , 2020, China CDC weekly.

[22]  G. Gao,et al.  A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019−2020 , 2020, China CDC weekly.

[23]  Moira Chan-Yeung,et al.  An Outbreak of Severe Acute Respiratory Syndrome among Hospital Workers in a Community Hospital in Hong Kong , 2003, Annals of Internal Medicine.